Table 3.
Model 1 | Model 2 | Model 3 | Model 4 | |||||
---|---|---|---|---|---|---|---|---|
B | SE | B | SE | B | SE | B | SE | |
Female | -0.209** | 0.076 | -0.232** | 0.075 | -0.202** | 0.076 | -0.183* | 0.076 |
BMI (kg/m2) | 0.024* | 0.012 | 0.029* | 0.012 | ||||
Symptoms of infection (0, 1) | 0.302** | 0.107 | 0.300** | 0.106 | ||||
Oral contraception (0, 1) | -0.637* | 0.298 | -0.666* | 0.297 | ||||
Urbanicity (0-70) | -0.007** | 0.003 | -0.008** | 0.003 | ||||
Education (yrs) | 0.161+ | 0.096 | 0.153 | 0.096 | ||||
Constant | 0.102 | 0.468 | 0.573*** | 0.052 | 0.885*** | 0.124 | 0.251 | 0.273 |
Model p value | <0.01 | <0.001 | <0.001 | <0.001 |
p<0.10;
p<0.05;
p<0.01;
p<0.001
Note: Models 1-3 consider gender as well as the separate associations of adiposity (model 1), pathogen exposure (model 2), and health behavior variables (model 3) shown in bivariate analyses to predict IL-10 at p<0.10. Model 4 considers all variables simultaneously to evaluate their independence in predicting IL-10.